Skip to main content
. 2013 Apr 18;2013:273086. doi: 10.1155/2013/273086

Table 1.

Consensus motifs and enzymes responsible for therapeutic modifications.

Modification type Linkage Consensus sequence Enzymes
N-glycosylation GlcNAc-Asn N-X-(S/T), X≠Pro OST
Mucin-type
O-glycosylation
GalNAc-Ser/Thr No consensus, Pro favorable ppGalNAcT
Disulfide bond –S–S– Cysteine pairs Ero1-PDI
γ-carboxylation Glu→Gla Mediated by adjacent propeptide GGCX-VKOR
β-hydroxylation Asn→Hyn; Asp→Hya C-X-D/N-X-X-X-X-F/Y-X-C-X-C
but not sufficient
β-hydroxylase
Tyrosine sulfation O4-sulfate ester No simple consensus site
Glu/Asp around Tyr favorable
TPST1/TPST2
Propeptide cleavage R/K ↓ With single or pair of basic amino acids PC family members
Phosphorylation pS, pT S-x-E/pS or Ser/Thr FAM20C or four-jointed
Amidation C-terminal carboxyl→amide C-terminal glycine PAM
Deamidation Asn→Asp; Gln→Glu Asn-Gly most susceptible Unknown or none
Glycation Ketoamine or Amadori product N-terminal primary amine
Or amino group of lysine side chain
Unknown or none
Pyroglutamate Pyrrolidone carboxylic acid N-terminal Gln or Glu Unknown or none
Oxidation Met→Met sulfoxide Met (Trp, Cys, Tyr, His) Unknown or none
Proteolytic processing Arg ↓ or ↓ Lys Basic amino acid APC, carboxypeptidase B